The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120
- PMID: 11457139
- DOI: 10.1021/ja004040e
The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120
Abstract
Cyanovirin-N (CVN) is a monomeric 11 kDa cyanobacterial protein that potently inactivates diverse strains of human immunodeficiency virus (HIV) at the level of cell fusion by virtue of high affinity interactions with the surface envelope glycoprotein gp120. Several lines of evidence have suggested that CVN-gp120 interactions are in part mediated by N-linked complex carbohydrates present on gp120, but experimental evidence has been lacking. To this end we screened a comprehensive panel of carbohydrates which represent structurally the N-linked carbohydrates found on gp120 for their ability to inhibit the fusion-blocking activity of CVN in a quantitative HIV-1 envelope-mediated cell fusion assay. Our results show that CVN specifically recognizes with nanomolar affinity Man(9)GlcNAc(2) and the D1D3 isomer of Man(8)GlcNAc(2). Nonlinear least squares best fitting of titration data generated using the cell fusion assay show that CVN binds to gp120 with an equilibrium association constant (K(a)) of 2.4 (+/- 0.1) x 10(7) M(-1) and an apparent stoichiometry of 2 equiv of CVN per gp120, Man(8)GlcNAc(2) D1D3 acts as a divalent ligand (2 CVN:1 Man(8)) with a K(a) of 5.4 (+/- 0.5) x 10(7) M(-1), and Man(9)GlcNAc(2) functions as a trivalent ligand (3 CVN:1 Man(9)) with a K(a) of 1.3 (+/- 0.3) x 10(8) M(-1). Isothermal titration calorimetry experiments of CVN binding to Man(9)GlcNAc(2) at micromolar concentrations confirmed the nanomolar affinity (K(a) = 1.5 (+/- 0.9) x 10(8) M(-1)), and the fitted data indicated a stoichiometry equal to approximately one (1 Man(9):1 CVN). The 1:1 stoichiometry at micromolar concentrations suggested that CVN has not only a high affinity binding site-relevant to the studies at nM concentrations-but a lower affinity site as well that facilitates cross-linking of CVN-oligomannose at micromolar concentrations or higher. The specificity of CVN for Man(8) D1D3 and Man(9) over the D1D2 isomer of Man(8) indicated that the minimum structure required for high affinity binding comprises Manalpha1 --> 2Manalpha. By following the (1)H-(15)N correlation spectrum of (15)N-labeled CVN upon titration with this disaccharide, we unambiguously demonstrate that CVN recognizes and binds to the disaccharide Manalpha1 --> 2Manalpha via two distinct binding sites of differing affinities located on opposite ends of the protein. The high affinity site has a K(a) of 7.2 (+/- 4) x 10(6) M(-1) and the low affinity site a K(a) of 6.8 (+/- 4) x 10(5) M(-1) as determined by isothermal titration calorimetry. Mapped surfaces of the carbohydrate binding sites are presented, and implications for binding to gp120 are discussed.
Similar articles
-
Solution structure of a cyanovirin-N:Man alpha 1-2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120.Structure. 2001 Oct;9(10):931-40. doi: 10.1016/s0969-2126(01)00653-0. Structure. 2001. PMID: 11591348
-
Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants.J Mol Biol. 2002 Apr 19;318(1):1-8. doi: 10.1016/S0022-2836(02)00045-1. J Mol Biol. 2002. PMID: 12054763
-
Site-specific discrimination by cyanovirin-N for alpha-linked trisaccharides comprising the three arms of Man(8) and Man(9).J Mol Biol. 2002 Sep 27;322(4):881-9. doi: 10.1016/s0022-2836(02)00842-2. J Mol Biol. 2002. PMID: 12270721
-
Properties of cyanovirin-N (CV-N): inactivation of HIV-1 by sessile cyanovirin-N (sCV-N).Dev Biol (Basel). 2000;102:141-8. Dev Biol (Basel). 2000. PMID: 10794101 Review.
-
Inhibition of HIV entry by carbohydrate-binding proteins.Antiviral Res. 2006 Sep;71(2-3):237-47. doi: 10.1016/j.antiviral.2006.02.004. Epub 2006 Mar 9. Antiviral Res. 2006. PMID: 16569440 Review.
Cited by
-
Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic-cell-directed HIV-1 transfer.J Virol. 2005 Nov;79(21):13519-27. doi: 10.1128/JVI.79.21.13519-13527.2005. J Virol. 2005. PMID: 16227272 Free PMC article.
-
Cyanovirin-N Binding to N-Acetyl-d-glucosamine Requires Carbohydrate-Binding Sites on Two Different Protomers.Biochemistry. 2024 May 21;63(10):1270-1277. doi: 10.1021/acs.biochem.4c00113. Epub 2024 Apr 9. Biochemistry. 2024. PMID: 38770609 Free PMC article.
-
Protocol for sorting cancer stem cells using a combination of anti-CD133 antibody and lectin cyanovirin-N.STAR Protoc. 2024 Dec 20;5(4):103443. doi: 10.1016/j.xpro.2024.103443. Epub 2024 Nov 19. STAR Protoc. 2024. PMID: 39565690 Free PMC article.
-
Inhibition of hepatitis C virus by the cyanobacterial protein Microcystis viridis lectin: mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNA.Mol Pharm. 2013 Dec 2;10(12):4590-4602. doi: 10.1021/mp400399b. Epub 2013 Nov 7. Mol Pharm. 2013. PMID: 24152340 Free PMC article.
-
Characterizing carbohydrate-protein interactions by nuclear magnetic resonance spectroscopy.Biopolymers. 2013 Oct;99(10):796-806. doi: 10.1002/bip.22329. Biopolymers. 2013. PMID: 23784792 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical